Anivive to Present Groundbreaking Research on First Systemic Antifungal Vaccine at World Vaccine Congress
WASHINGTON, April 4, 2024 /PRNewswire/ -- Anivive Lifesciences, is set to unveil groundbreaking research at the upcoming World Vaccine Congress , where they will present findings on the development of the world's first systemic antifungal vaccine – A solution for both ends of the leash.
- WASHINGTON, April 4, 2024 /PRNewswire/ -- Anivive Lifesciences, is set to unveil groundbreaking research at the upcoming World Vaccine Congress , where they will present findings on the development of the world's first systemic antifungal vaccine – A solution for both ends of the leash.
- I am honored to share our findings at the World Vaccine Congress and contribute to the global dialogue on vaccine innovation."
- The World Vaccine Congress serves as a premier platform for sharing cutting-edge research and fostering collaboration among experts in the field of vaccinology.
- For more information about Dr. Robb's presentation and the World Vaccine Congress, please visit Anivive.com